Description: The global Crohn’s Disease market is projected to achieve robust growth over the next decade, propelled by increasing disease prevalence and the expanding use of advanced therapies. Crohn’s Disease, a chronic type of inflammatory bowel disease (IBD), represents a substantial and critical segment within the gastroenterology therapeutics space. The market size, valued at USD 10.21 billion in 2024, is expected to reach USD 13.65 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 3.70% over the forecast period. Based on this trajectory, the market size for the year 2025 is forecast to be approximately USD 10.59 billion, indicating sustained, steady expansion.
Category:
Tag: Crohn's Disease Market